Funding Opportunities

At the intersection of innovation and academic excellence, we are dedicated to advancing groundbreaking research and fostering collaborations that translate intellectual capital into real-world impact. This page allows researchers, entrepreneurs, and industry partners to explore various funding avenues available to propel innovative ideas from conception to commercialization.
Explore various funding programs, grants, and partnership possibilities and embark on a journey of discovery and innovation with Georgetown University’s Office of Technology Commercialization.

Gap Fund

The Georgetown University Medical Center Gap Fund supports promising medical research by providing annual funding of up to $100,000 per project for one year. Established in 2021 through a $1M gift from Bill and Ruth Baker, the fund bridges the gap in early-stage biomedical research, aiding projects with proof of concept and societal impact potential.

This collaboration between the Office of Advancement and the Office of Technology Commercialization aims to enhance Georgetown’s entrepreneurial ecosystem for medical research. Bill Baker, an alumnus and dedicated Georgetown parent, has played a key role in the university’s community and served on the Board of Directors and Board of Regents, contributing significantly to initiatives such as the sale of Georgetown University Hospital to MedStar Health.

It is my hope that this fund acts as a catalyst for the university’s growing entrepreneurial culture. I believe it will increase investments and partnerships within the university community to create common good.

Bill Baker

Accelerating Research Translation (ART)

The National Science Foundation (NSF) aims to accelerate the translation of academic research into practical solutions that benefit the public through the “Accelerating Research Translation” (ART) program. This initiative primarily focuses on building capacity and infrastructure for translational research at U.S. Institutions of Higher Education (IHEs) and enhancing their role in regional innovation ecosystems. It also seeks to provide effective training for graduate students and postdoctoral researchers in translational research, benefiting them in various career options.

Key points regarding the ART program:

The solicitation calls for proposals enabling IHE-based teams to blend activities, including:

Funded teams will become a nationwide network of ‘ART Ambassadors,’ advocating for the cause of translational research.

Other Opportunities

TEDCO is Maryland’s technology development corporation that provides funding, resources, and connections to early-stage technology and life sciences companies. It aims to foster innovation and economic development within the state, supporting entrepreneurs to thrive in Maryland’s ecosystem.

New Atlantic Ventures is a venture capital firm based in Virginia, founded in 1999. It focuses on investing in early-stage ventures in sectors such as mobile, e-commerce, cybersecurity, education, ad tech, and healthcare.

VIPC (Virginia Innovation Partnership Corporation) is a state-backed organization that accelerates innovation and economic growth in Virginia. It provides funding, resources, and support to startups and early-stage companies across various technology sectors.

VentureWell is a nonprofit organization that supports early-stage science and technology innovators and entrepreneurs through funding, training, and networking opportunities. It focuses on helping inventors and entrepreneurs bring their ideas from lab to market.

Osage University Partners is a venture capital firm that invests in startups and companies emerging from university research. It partners with leading institutions to help commercialize breakthrough technologies and innovations developed in academic settings.

DC I-Corps is a regional program of the National Science Foundation’s Innovation Corps (I-Corps) initiative. It provides entrepreneurship training and mentoring to help researchers and students translate their technological innovations into commercially viable products and services.

Back to top